People · Operator
Named in public records as an officer, director or promoter · active 2017–2018 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Meves Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $10.9M | $337.8M | 2018 |
| Corino Therapeutics, Inc. | — | Biotechnology | Seed | $3.5M | $154.3M | 2017 |
Peter Barber at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Barber on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rishi Gupta | 1 | 12 |
| Ben Auspitz | 1 | 9 |
| Timothy McInerney | 1 | 4 |
| Jay Moorin | 1 | 4 |
| Joshua Grass | 1 | 2 |
| Daniel DiPietro | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.